Figure 1. Risk Of Breast Cancer With Combined Oral Contraceptive Use (Image 01)
Xelria Fe Kit
Product Images NDC 70700-308
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Xelria Fe (NDC 70700-308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Xiromed Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Norethindrone And Ethinyl Estradiol Structural Formulas (Image 02)
Patient Information Figure 1 (Image 03)
This text provides information on different methods of birth control and their effectiveness in preventing pregnancies. It categorizes the effectiveness of birth control methods based on the number of pregnancies per 100 women in one year, ranging from fewer than 1 pregnancy to 85 or more pregnancies. It also lists various birth control methods such as injections, intrauterine devices, birth control pills, skin patch, vaginal ring with hormones, fertile days of the monthly cycle, spermicide, withdrawal, and no birth control.*
Figure A (Image 04)
The text appears to contain information about a medication with the active ingredients Norethindrone and Ethinyl Estradiol, in addition to Ferrous Fumarate. It specifies the dosage as 0.4 mg of Norethindrone and 0.035 mg of Ethinyl Estradiol. The medication is in the form of chewable tablets and is indicated for oral use. A storage instruction is also provided - "Store at 20-25°C (68-77°F)," and the package contains 28 tablets. The document includes an image labeled as "Figure A."*
Norethindrone And Ethinyl Estradiol Chewable Tablets And Ferrous Fumarate Chewable Tablets 0.4 mg/0.035 mg Carton Label (Image 05)
This text appears to be a detailed description of a pharmaceutical product called Xelria™ Fe. It consists of Norethindrone and Ethinyl Estradiol Tablets along with Ferrous Fumarate Tablets, both in chewable form. The product is designed as an oral contraceptive to prevent pregnancy and does not provide protection against infections or sexually transmitted diseases. Each package contains three pouches, with each pouch containing a blister pack of 28 tablets. The tablets contain a specific dosage of Norethindrone and Ethinyl Estradiol (0.4 mg/0.035 mg) and Ferrous Fumarate.*
Figure B (Image 06)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
